1. Home
  2. TBPH
  3. TBPH News

Latest Theravance Biopharma Inc. (TBPH) News on November 4, 2025

How Recent Developments Are Changing the Theravance Biopharma Investment Story
TBPH

Simply Wall St.

a month ago

How Recent Developments Are Changing the Theravance Biopharma Investment Story

Viatris gains China approval for Yupelri to treat COPD
TBPH

Pharmaceutical Technology

4 months ago

Viatris gains China approval for Yupelri to treat COPD

TBPH

MT Newswires

4 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Thursday

TBPH

MT Newswires

4 months ago

Sector Update: Health Care

TBPH

MT Newswires

4 months ago

Theravance Biopharma Earns $7.5 Million Milestone Payment After COPD Drug Wins China Approval

Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA
TBPH

PR Newswire

4 months ago

Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA

TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises
TBPH

Zacks

5 months ago

TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises

TBPH

MT Newswires

5 months ago

Theravance to Sell Remaining Royalty Interest in Trelegy Ellipta Sales to GSK for $225 Million

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million
TBPH

PR Newswire

5 months ago

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable
TBPH

Simply Wall St.

5 months ago

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

6 months ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y
TBPH

Zacks

6 months ago

Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress
TBPH

PR Newswire

6 months ago

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress

Theravance Biopharma Inc (TBPH) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...
TBPH

GuruFocus.com

6 months ago

Theravance Biopharma Inc (TBPH) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...

Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
TBPH

Zacks

6 months ago

Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates

Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
TBPH

PR Newswire

6 months ago

Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

Theravance Biopharma Inc (TBPH) Q1 2025 Earnings Report Preview: What To Expect
TBPH

GuruFocus.com

6 months ago

Theravance Biopharma Inc (TBPH) Q1 2025 Earnings Report Preview: What To Expect

Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress
TBPH

PR Newswire

6 months ago

Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress

Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
TBPH

PR Newswire

6 months ago

Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Theravance Biopharma Presents Two New Ampreloxetine Analyses in Oral Session at the American Academy of Neurology 2025 Annual Meeting
TBPH

PR Newswire

7 months ago

Theravance Biopharma Presents Two New Ampreloxetine Analyses in Oral Session at the American Academy of Neurology 2025 Annual Meeting

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

7 months ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Why Is Theravance Bio (TBPH) Up 0.4% Since Last Earnings Report?
TBPH

Zacks

7 months ago

Why Is Theravance Bio (TBPH) Up 0.4% Since Last Earnings Report?

Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology
TBPH

PR Newswire

7 months ago

Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology

Theravance Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
TBPH

Simply Wall St.

8 months ago

Theravance Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Theravance's Q4 Loss In Line With Estimates, Sales Beat
TBPH

Zacks

8 months ago

Theravance's Q4 Loss In Line With Estimates, Sales Beat

Theravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ...
TBPH

GuruFocus.com

8 months ago

Theravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ...

Theravance Biopharma (TBPH) Reports Q4 Loss, Tops Revenue Estimates
TBPH

Zacks

8 months ago

Theravance Biopharma (TBPH) Reports Q4 Loss, Tops Revenue Estimates

Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results
TBPH

PR Newswire

8 months ago

Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results

Earnings To Watch: Theravance Biopharma Inc (TBPH) Reports Q4 2024 Result
TBPH

GuruFocus.com

8 months ago

Earnings To Watch: Theravance Biopharma Inc (TBPH) Reports Q4 2024 Result

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

8 months ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation
TBPH

Simply Wall St.

9 months ago

Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation

Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
TBPH

PR Newswire

9 months ago

Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

9 months ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock?
TBPH

Zacks

9 months ago

Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
TBPH

TipRanks

10 months ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Analysts Are Optimistic We'll See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH)
TBPH

Simply Wall St.

10 months ago

Analysts Are Optimistic We'll See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH)

Government Contractor KBR, Recently Hit by DOGE Fears, Draws Activist Investor
TBPH

The Wall Street Journal

a year ago

Government Contractor KBR, Recently Hit by DOGE Fears, Draws Activist Investor

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
TBPH

PR Newswire

a year ago

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference

Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?
TBPH

Zacks

a year ago

Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable
TBPH

Simply Wall St.

a year ago

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

a year ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TBPH

Simply Wall St.

a year ago

Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y
TBPH

Zacks

a year ago

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...
TBPH

GuruFocus.com

a year ago

Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...

Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates
TBPH

Zacks

a year ago

Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates

Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
TBPH

PR Newswire

a year ago

Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?
TBPH

Zacks

a year ago

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
TBPH

Zacks

a year ago

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings
TBPH

GuruFocus.com

a year ago

What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings

5 Small Drug Stocks to Buy as Trump Gets Re-Elected
TBPH

Zacks

a year ago

5 Small Drug Stocks to Buy as Trump Gets Re-Elected

Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
TBPH

PR Newswire

a year ago

Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024

Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
TBPH

PR Newswire

a year ago

Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease

Seth Klarman's Complete Exit from Theravance Biopharma Inc
TBPH

GuruFocus.com

a year ago

Seth Klarman's Complete Exit from Theravance Biopharma Inc

Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report?
TBPH

Zacks

a year ago

Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report?

Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation
TBPH

Simply Wall St.

a year ago

Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation

Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
TBPH

Zacks

a year ago

Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

a year ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Seth Klarman's Strategic Reduction in Theravance Biopharma Inc
TBPH

GuruFocus.com

a year ago

Seth Klarman's Strategic Reduction in Theravance Biopharma Inc

Need To Know: Analysts Just Made A Substantial Cut To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Estimates
TBPH

Simply Wall St.

a year ago

Need To Know: Analysts Just Made A Substantial Cut To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Estimates

Theravance Biopharma Second Quarter 2024 Earnings: Misses Expectations
TBPH

Simply Wall St.

a year ago

Theravance Biopharma Second Quarter 2024 Earnings: Misses Expectations

TBPH

MT Newswires

a year ago

Leerink Partners Downgrades Theravance Biopharma to Market Perform From Outperform, Adjusts PT to $10 From $15

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y
TBPH

Zacks

a year ago

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y

Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates
TBPH

Zacks

a year ago

Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

a year ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma, Inc. (NASDAQ:TBPH): When Will It Breakeven?
TBPH

Simply Wall St.

a year ago

Theravance Biopharma, Inc. (NASDAQ:TBPH): When Will It Breakeven?

Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024
TBPH

PR Newswire

a year ago

Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024

Best Momentum Stocks to Buy for July 15th
TBPH

Zacks

a year ago

Best Momentum Stocks to Buy for July 15th

Investors in Theravance Biopharma (NASDAQ:TBPH) have unfortunately lost 52% over the last five years
TBPH

Simply Wall St.

a year ago

Investors in Theravance Biopharma (NASDAQ:TBPH) have unfortunately lost 52% over the last five years

Here's Why You May Invest in Theravance (TBPH) Stock Now
TBPH

Zacks

a year ago

Here's Why You May Invest in Theravance (TBPH) Stock Now

Wall Street Analysts Predict a 90.53% Upside in Theravance Bio (TBPH): Here's What You Should Know
TBPH

Zacks

a year ago

Wall Street Analysts Predict a 90.53% Upside in Theravance Bio (TBPH): Here's What You Should Know

Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?
TBPH

Zacks

a year ago

Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?

Sidoti Events, LLC's Virtual June Small-Cap Conference
TBPH

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual June Small-Cap Conference

High Insider Ownership Growth Companies On US Exchange May 2024
TBPH

Simply Wall St.

a year ago

High Insider Ownership Growth Companies On US Exchange May 2024

Theravance Biopharma First Quarter 2024 Earnings: Beats Expectations
TBPH

Simply Wall St.

a year ago

Theravance Biopharma First Quarter 2024 Earnings: Beats Expectations

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
TBPH

Zacks

a year ago

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates

TBPH

MT Newswires

a year ago

Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours

Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
TBPH

Zacks

a year ago

Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates

Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
TBPH

PR Newswire

a year ago

Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

a year ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
TBPH

PR Newswire

2 years ago

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024

Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
TBPH

Zacks

2 years ago

Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
TBPH

PR Newswire

2 years ago

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
TBPH

Zacks

2 years ago

Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?

Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
TBPH

Zacks

2 years ago

Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript
TBPH

Insider Monkey

2 years ago

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
TBPH

Zacks

2 years ago

Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates

Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
TBPH

Zacks

2 years ago

Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates

TBPH

Associated Press Finance

2 years ago

Theravance Bio: Q4 Earnings Snapshot

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
TBPH

PR Newswire

2 years ago

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Theravance Biopharma to Participate in an Upcoming Investor Conference
TBPH

PR Newswire

2 years ago

Theravance Biopharma to Participate in an Upcoming Investor Conference

Will Theravance Biopharma (NASDAQ:TBPH) Spend Its Cash Wisely?
TBPH

Simply Wall St.

2 years ago

Will Theravance Biopharma (NASDAQ:TBPH) Spend Its Cash Wisely?

Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
TBPH

PR Newswire

2 years ago

Theravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

TBPH

Reuters

2 years ago

US court sets expedited schedule for JetBlue, Spirit merger rejection appeal

Spirit Airlines (SAVE) to Report Q4 Earnings: What's in Store?
TBPH

Zacks

2 years ago

Spirit Airlines (SAVE) to Report Q4 Earnings: What's in Store?

Dine Brands Global Named to Newsweek’s America’s Greatest Workplaces for Diversity 2024
TBPH

Business Wire

2 years ago

Dine Brands Global Named to Newsweek’s America’s Greatest Workplaces for Diversity 2024

The Zacks Analyst Blog Highlights Yum! Brands, Hexcel, Arthur J. Gallagher, United Rentals and Heritage Financial
TBPH

Zacks

2 years ago

The Zacks Analyst Blog Highlights Yum! Brands, Hexcel, Arthur J. Gallagher, United Rentals and Heritage Financial

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios
TBPH

Zacks

2 years ago

Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios

Why Is Fiverr (FVRR) Stock Rocketing Higher Today
TBPH

StockStory

2 years ago

Why Is Fiverr (FVRR) Stock Rocketing Higher Today

United Kingdom Anti-Fog Lidding Films Market: In-Depth Analysis and Forecast Until 2030
TBPH

GlobeNewswire

2 years ago

United Kingdom Anti-Fog Lidding Films Market: In-Depth Analysis and Forecast Until 2030

TBPH

Business Wire

2 years ago

SmartRent to Report Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Share on Social Networks: